Buonerba, C., De Placido, P., Bruzzese, D., Pagliuca, M., Ungaro, P., Bosso, D., . . . Di Lorenzo, G. (2018). Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial. Front Pharmacol.
Παραπομπή Chicago StyleBuonerba, Carlo, et al. "Isoquercetin As an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial." Front Pharmacol 2018.
Παραπομπή MLABuonerba, Carlo, et al. "Isoquercetin As an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial." Front Pharmacol 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.